Description:
Home Page: onconetix.gcs-web.com
201 East Fifth Street
Cincinnati,
OH
45202
United States
Phone:
513 620 4101
Officers
| Name | Title |
|---|---|
| Ms. Erin Henderson | Consultant |
| Dr. Ralph Schiess Ph.D. | Interim CEO & Chief Science Officer |
| Mr. Bruce Harmon | Chief Financial Officer |
| Dr. Brian Price Ph.D. | Head of Technology Strategy |
| Mr. Frank A. Jaeger M.A., M.B.A. | Senior VP of Marketing & Business Development |
| Mr. Andrew D. Skibo Ph.D. | Global Head of Biologics Operations |
| Mr. Theodore Scott Yoho | Head of Business Development |
| Dr. Ali I. Fattom Ph.D. | Head of Science & Discovery |
| Dr. Jay Newmark M.B.A., M.D. | Chief Medical Officer |
| Mr. Christian Bruhlmann | Chief Strategy Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.3673 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2022-02-18 |
| Fiscal Year End: | December |
| Full Time Employees: | 12 |